Performance Period: 2/1/2019 to 12/31/2020
Single-use technology has been widely adopted in the biopharmaceutical industry. Results from a 2015 survey reported in BioPharm International show that 87% of respondents to a “manufacturing trends and outlook” survey reported using single-use components in their processes[1]. Despite the wide adoption of single-use technology, the availability of hands-on training opportunities, particularly those that incorporate an actual bioprocess, are limited.
This is the first phase of a larger project that will assemble the single-use equipment and develop a process for monoclonal antibody (mAb) production in CHO to be used for education/training and development projects. The project would lead to the first dedicated single-use mAb production process for education, training, testing and development of which we are aware.
[1] R. Peters, "Technologies and Practices Must Evolve to Meet Demand,” BioPharm International, Vol 28 (1) 2015
Development of the first dedicated single-use mAb production process for education, training, testing and development
Login to the NIIMBL member portal to access more, including:
Not yet a member? Learn more about which level of NIIMBL membership is right for you and your organization.
North Carolina State University
